Buys
Open market- Shares
- Avg price
- Total value
Brent Sabatini - SVP, Chief Accounting Officer at Vir Biotechnology, Inc.
Issuer-level insider activity
- Role
- SVP, Chief Accounting Officer
- Issuer ticker
- VIR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Brent Sabatini in Vir Biotechnology, Inc.
Sells
Open market- Shares
- -12,879
- Avg price
- $8.78
- Total value
- -$113,087
Net
Past year- Shares
- -12,879
- Share %
- -100%
- Total value
- -$113,087
Reported holdings for Brent Sabatini in Vir Biotechnology, Inc.
Form 4 holding
SVP, Chief Accounting Officer
Vir Biotechnology, Inc.
- Security class
- Common Stock
- Shares / value
- 61,902
- Estimated value
- $584,973
- Report date
- 01 Jun 2026
- Price
- $9.45
- Ownership
- Direct
Form 4 holding
SVP, Chief Accounting Officer
Vir Biotechnology, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 50,000
- Estimated value
- $61,200
- Report date
- 22 Feb 2026
- Price
- $1.53
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Brent Sabatini in Vir Biotechnology, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.